Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers

Conditions

• Chronic Lymphocytic Leukemia
• Indolent B-cell Lymphomas
• Chronic Hepatitis B
• Lymphoma, Small Lymphocytic
• Mantle-Cell Lymphoma
• Waldenstrom's Macroglobulinaemia
• Follicular Lymphoma

Interventions

• DRUG: Ibrutinib

Sponsor

The University of Hong Kong

Collaborators

• [object Object]